Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation

Published:2020 Issue:35 Volume:35 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Jeon Doosoo¹^ORCID,Kang Hyungseok²^ORCID,Kwon Yong-Soo³^ORCID,Yim Jae-Joon⁴^ORCID,Shim Tae Sun⁵^ORCID

Affiliation:

1. Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.

2. Department of Chest Medicine, Masan National Tuberculosis Hospital, Masan, Korea.

3. Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

5. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Korea Centers for Disease Control and Prevention

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2020.35.e284

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview;Tuberculosis;2024-09

2. Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy;Pharmaceutics;2024-05-17

3. Compliance with new drug use and the effect of discrepant drug susceptibility testing on MDR/RR-TB treatment;The International Journal of Tuberculosis and Lung Disease;2024-02-01

4. Diagnosis and Treatment Pathway of MDR/RR-TB in Taizhou, Zhejiang Province, China;Tropical Medicine and Infectious Disease;2023-01-21

5. Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST);Journal of Korean Medical Science;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3